CNS, Neurotransmission Flashcards
How do Neurons Differ from Other Cells?
Neurons do not reproduce or replace themselves to the same degree as other cells
Neuroplasticity: No other cells adapt by altering inter-cellular connections
Neuron / Action Potential Recap
Negatively charged ions produce inhibitory effect – prevent action potential
Action potential from depolarization
Axon terminals – pass impulse to neighboring cell
Electrical signal becomes a chemical signal through neurotransmission
Psychotropic medications alter these processes
*drugs have effects on pathways
Neuroplasticity
Brain learns which connections to strengthen, develops pathways
Reroute pathway, reform function = plasticity through protein synthesis–learning
Nerve cells are constantly adapting, very gradual
Similar to photokinesis, leaves turn to face the light
• e.g. time needed after stroke to regain functionality– new neural connections to replace those are destroyed
Pruning
Dendrites and axon branches are continuously removing old connections and establishing new connections with neighboring cells
Begins soon after birth continues throughout life
Dramatic pruning increases in late adolescence
Some evidence that pruning process may precipitate emergence of SZ
Terminating Neurotransmission: Diffusion
NT molecules drift outside synapse altogether into extracellular space
No receptors to bind with, eventually metabolized
Terminating Neurotransmission: Deactivation in Synapse
e.g. MAO
e.g. COMPT
• Cutting atoms from ends of NT molecule
• Can’t fit in lock-and–key to dendrite
Terminating Neurotransmission: Negative feedback
NT binds to autoreceptor on pre-synaptic neuron which signals the shut off of NT release
Terminating Neurotransmission: Reuptake
Reuptake sites on presynaptic membranes
→5HT transporter proteins
Specific to each type of NT, each has its own proteins for reuptake
o “like little mini hoover vacuum cleaners” that retrieve neurotransmitter from the synapse
Return NT to presynaptic vesicles for reuse
Terminating Neurotransmission: Deactivation inside axon terminal
After the NT molecules are returned to the neuron by transporter reuptake proteins, they have a brief moment of freedom
They are unprotected in the neuron, haven’t been recaptured yet by the vesicle
They are quickly gathered and stored within the vesicle, protected and held for future use
→but during that brief interval, NT is vulnerable to deactivation by MAO
Common NT’s in brain that we know of
5HT
Norepinephrine
Dopamine
→–most drugs work on these systems
*there are different subtypes of receptors for each NT
o e.g. 14 different subtypes of 5HT receptors
Also: GABA Cannabinoids Glutamate Acetylcholine
Neuropeptides—different class, we don’t know too much about
Opiate peptides: Naturally occurring opiates in the brain that interact with the opiate receptors
o Heroin
o Morphine
o Many others
Melatonin – neural hormone created by pineal gland
o circadian rhythms
o sleep regulation
2nd Messenger System
2nd messenger = protein that carries signal inside postsynaptic neuron after NT binds to a postsynaptic receptor
Eventually leads to signal transduction, potentially changing the chemical makeup of the neuron, how it responds
*very complicated and very poorly understood
Receptor occupancy happens immediately
- bx and emotional changes take time
- may explain delayed clinical effect of psychotropic medications (e.g. 6 weeks Prozac)
G proteins, specific type of 2nd messenger linked to DA receptors
Partial Agonism
“3rd generation” AP’s (Abilify, Buspar)
Not as effective as natural NT
*Weak agonist at low levels of naturally occuring NT’s
- Works like antagonist when high ocurring NT’s, but doesn’t stimulate as much as a naturally ocurring NT
- Net effect based on naturally occurring levels
Receptors, general
Receptors are dynamically frequently changing entities, with variability in:
Amount of receptors available
Sensitivity
Number of receptor sites
Density
Binding capacity
Downregulation
Agonistic drugs increase the action on a receptor
Neuron compensates:
*expressing fewer receptors on its membrane or *decreases binding efficacy
Result: receptors become less sensitive to medication
Upregulation
Antagonist decreases receptor binding to NT
Body responds by producing more receptors and increases binding efficiency to counter the lower neurotransmitter levels→ homeostasis